Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its structure supports the development of novel therapeutics with potential applications in treating neurodegenerative diseases and psychiatric conditions. The compound's scaffold is valued for its ability to cross the blood-brain barrier, making it suitable for CNS-active drug design. Additionally, it serves as a building block in medicinal chemistry for optimizing pharmacokinetic properties in new drug candidates.